載入...
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
BACKGROUND: The basal-like breast cancer (BLBC) subtype is characterized by positive staining for basal mammary epithelial cytokeratin markers, lack of hormone receptor and HER2 expression, and poor prognosis with currently no approved molecularly-targeted therapies. The oncogenic signaling pathways...
Na minha lista:
發表在: | BMC Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4971667/ https://ncbi.nlm.nih.gov/pubmed/27484095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2609-2 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|